BNET Industries

DOV Pharmaceutical Inc.

(DOVP) is in the Pharma Industry

Market Cap:$2.0M
Last Fiscal Year Sales:$10.2M
  • Public
  • US
Dow Jones Description

Developer of Drugs for Central Nervous System, Cardiovascular & Urological Disorders

Chief Accounting Officer and Controller
William Kaltnecker
Number of Employees 12
Contact Information

150 Pierce St

Somerset, New Jersey 08873-4185

www.dovpharm.co...

(732) 907-3600

NAICS Code Pharmaceutical Preparation Manufacturing: 325412

News & Analysis

dov pharmaceutical inc. - All News and Analysis

Decision Makers

Name (plus bio) Position
William Kaltnecker Chief Accounting Officer and Controller
Robert Horton Senior Vice President, General Counsel and Secretary
Scott D. Myers Senior Vice President, Marketing and Commercialization
Warren Stern Senior Vice President, Drug Development and Assistant Secretary
Zhengming Chen Director of Chemistry
David H Farb Professor
John W Daly Chemist, Pharmacologist
Barbara G. Duncan CEO
Patrick Ashe Director
Zola P. Horovitz Director

Board of Directors

Name (plus bio) Position
Daniel S. Van Riper Chairman
Daniel A. Van Riper Board of Directors
Dennis Podlesak Board of Directors

Organization Position Status
DOV Pharmaceutical, Inc. Chief Accounting Officer and Controller Current

Organization Position Status
DOV Pharmaceutical, Inc. Senior Vice President, General Counsel and Secretary Current

Organization Position Status
DOV Pharmaceutical, Inc. Senior Vice President, Marketing and Commercialization Current

Organization Position Status
DOV Pharmaceutical, Inc. Senior Vice President, Drug Development and Assistant Secretary Current
Jubilant Biosys Ltd. Senior Vice President, Drug Development, Innovation Current
PAREXEL International Corporation Senior Vice President of Scientific and Medical Services Former
Jubilant Biosys Ltd. Consultant Former
DOV Pharmaceutical, Inc. Consultant Former
Indiana University Ph.D. In Psychopharmacology Former

Organization Position Status
DOV Pharmaceutical, Inc. Director of Chemistry Current
Midwest Laboratory Robotics Interest Group, Inc Treasurer, Lrig Mid Atlantic, Committee, Computational Methods Current
Midwest Laboratory Robotics Interest Group, Inc Board of Directors Current
Purdue Pharma L.P. Principal Investigator Former
University of New Orleans Ph.D. Former
Wuhan University B.Sc Former

Organization Position Status
DOV Pharmaceutical, Inc. Professor Current
Aspet President Former
Boston University School of Medicine Chairman of the Department of Pharmacology and Experimental Therapeutics Former
Brandeis University Ph.D. In Biochemistry Former
Long Island University B.A. In Chemistry Former

John W. Daly, Ph.D. is an internationally known chemist/pharmacologist. Now a scientist emeritus in the National Institute of Diabetes and Digestive and Kidney Diseases, Dr. Daly was chief of NIDDK's Laboratory of Bioorganic Chemistry, a laboratory he founded and headed from 1981 to 1997. Natural products discovered through the research of Dr. Daly's lab, primarily alkaloids derived from amphibian skin, have had a major impact on knowledge of how the nervous system functions and how drugs interact with the nervous system. During Dr. Daly's 40-year tenure at NIH, his numerous accomplishments have included the discovery of the "NIH Shift" an unexpected molecular process involved in the conversion of the amino acids phenylalanine and tryptophan to the important neurotransmitters dopamine, norepinephrine and serotonin. Author of more than 500 research papers, a book ( Cyclic Nucleotides in the Nervous System ) and many book chapters, Dr. Daly was elected to the National Academy of Sciences in 1997. Among his many other honors are the Hillebrand Award from the American Chemical Society in 1978, the Research Achievement Award from the American Society of Pharmacognosy in 1997, the Karl Wilhelm Scheele Award from the Swedish Academy of Pharmaceutical Sciences in 1999 and in 2002, the American Chemical Society's Ernest Guenther Award in the Chemistry of Natural Products. That same year, he was also named among the most-cited pharmacologists in the world.

Organization Position Status
DOV Pharmaceutical, Inc. Chemist, Pharmacologist Current

Organization Position Status
New Brunswick Scientific Company, Inc. Independent Financial Consultant Current
DOV Pharmaceutical, Inc. Chairman Current
3D Systems Corporation Board of Directors Current
New Brunswick Scientific Company, Inc. Board of Directors Current
Sealed Air Corporation Chief Financial Officer Former
Sealed Air Corporation Senior Vice President Former
Sealed Air Corporation Advisor Former
DOV Pharmaceutical, Inc. Director Former
Millennium Chemicals Inc. Director Former

Array

Organization Position Status
DOV Pharmaceutical, Inc. Board of Directors Current
DOV Pharmaceutical, Inc. President & CFO Former
Wharton Graduate School of the University of Pennsylvania M.B.A. Former
Louisiana State University B.S. Former

Organization Position Status
DOV Pharmaceutical, Inc. Board of Directors Current

Organization Position Status
Domain Associates LLC Partner Current
Prevent Blindness Partner Current
Prevent Blindness Director Current
DOV Pharmaceutical, Inc. Board of Directors Current
AVANIR Pharmaceuticals Board of Directors Current
Johnson & Johnson Chief Executive Officer Former
Peninsula Pharmaceuticals, Inc. Chief Executive Officer Former
Cerexa, Inc. Chief Executive Officer Former
Novartis AG Senior Vice President Former
Allergan, Inc. Vice President Former
Allergan, Inc. Head of the Cec Division Former
Novartis AG Head Former
Domain Associates LLC Principal Former
GlaxoSmithKline Plc Former
Cerexa, Inc. Board of Directors Former
Peninsula Pharmaceuticals, Inc. Board of Directors Former
Pepperdine University M.B.A. Former
Pepperdine University B.A. In Business Administration Former

Organization Position Status
DOV Pharmaceutical, Inc. Director Current
Businessschool M.B.A. Former
University College Dublin B.Sc. In Pharmacology Former

Organization Position Status
Sage Healthcare, Ltd. Current
Phyton, Inc. Chairman Current
GenVec, Inc. Chairman Current
Immunicon Corporation Chair Current
Genaera Corporation Chairman Current
BioCryst Pharmaceuticals, Inc. Director, Chairman of The Board Current
Xintria Pharmaceutical Corporation Member of Dov Pharmaceuticals Board of Directors Current
Palatin Technologies Inc. Board of Directors Current
Avigen, Inc. Director Current
BioCryst Pharmaceuticals, Inc. Director Current
NitroMed, Inc. Director Current
International Fight League, Inc. Director Current
DOV Pharmaceutical, Inc. Director Current
Immunicon Corporation Director Current
NitroMed, Inc. Committee Member Current
Avigen, Inc. Vice President, Business Development Former
Bristol-Myers Squibb Company Vice President, Business Development and Planning Former
Bristol-Myers Squibb Company Associate Director Former
Bristol-Myers Squibb Company Liaison Former
Phyton, Inc. Director Former
Princeton University Board of Directors Former
GenVec, Inc. Director Former
University of Pittsburgh Ph.D. In Pharmacology Former
University of Pittsburgh M.S. In Pharmacology Former
University of Pittsburgh B.S. In Pharmacy Former

Executive News

  • Domain Associates LLC Raises 8th Venture Fund

    Business Wire - 8/10/09 - View Story

advertisement
     DOVP $0.02 0.00 (0.00% )
Intraday | 3 Month | 6 Month | 1 Year
Average Volume 53,942
Shares Outstanding 111.51M
Market Cap 2.0M
Year High 0.07
Year Low 0.0013
Earnings Per Share N/A
P/E Ratio -
Dividend N/A
Yield N/A
IndustryTop Rated
advertisement
Click Here